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Objective: Binding of ghrelin to its receptor, growth hormone secretagogue receptor (GHSR), stimulates GH release, induces eating, and in-
creases blood glucose. These processes may also be influenced by constitutive (ghrelin-independent) GHSR activity, as suggested by findings in
short people with naturally occurring GHSR-A204E mutations and reduced food intake and blood glucose in rodents administered GHSR inverse
agonists, both of which impair constitutive GHSR activity. In this study, we aimed to more fully determine the physiologic relevance of constitutive
GHSR activity.
Methods: We generated mice with a GHSR mutation that replaces alanine at position 203 with glutamate (GHSR-A203E), which corresponds to
the previously described human GHSR-A204E mutation, and used them to conduct ex vivo neuronal electrophysiology and in vivo metabolic
assessments. We also measured signaling within COS-7 and HEK293T cells transfected with wild-type GHSR (GHSR-WT) or GHSR-A203E
constructs.
Results: In COS-7 cells, GHSR-A203E resulted in lower baseline IP3 accumulation than GHSR-WT; ghrelin-induced IP3 accumulation was
observed in both constructs. In HEK293T cells co-transfected with voltage-gated CaV2.2 calcium channel complex, GHSR-A203E had no effect on
basal CaV2.2 current density while GHSR-WT did; both GHSR-A203E and GHSR-WT inhibited CaV2.2 current in the presence of ghrelin. In cultured
hypothalamic neurons from GHSR-A203E and GHSR-deficient mice, native calcium currents were greater than those in neurons from wild-type
mice; ghrelin inhibited calcium currents in cultured hypothalamic neurons from both GHSR-A203E and wild-type mice. In brain slices, resting
membrane potentials of arcuate NPY neurons from GHSR-A203E mice were hyperpolarized compared to those from wild-type mice; the same
percentage of arcuate NPY neurons from GHSR-A203E and wild-type mice depolarized upon ghrelin exposure. The GHSR-A203E mutation did not
significantly affect body weight, body length, or femur length in the firstw6 months of life, yet these parameters were lower in GHSR-A203E mice
after 1 year of age. During a 7-d 60% caloric restriction regimen, GHSR-A203E mice lacked the usual marked rise in plasma GH and
demonstrated an exaggerated drop in blood glucose. Administered ghrelin also exhibited reduced orexigenic and GH secretagogue efficacies in
GHSR-A203E mice.
Conclusions: Our data suggest that the A203E mutation ablates constitutive GHSR activity and that constitutive GHSR activity contributes to the
native depolarizing conductance of GHSR-expressing arcuate NPY neurons. Although the A203E mutation does not block ghrelin-evoked signaling
as assessed using in vitro and ex vivo models, GHSR-A203E mice lack the usual acute food intake response to administered ghrelin in vivo. The
GHSR-A203E mutation also blunts GH release, and in aged mice leads to reduced body length and femur length, which are consistent with the
short stature of human carriers of the GHSR-A204E mutation.
 2020 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In their seminal paper, Kojima et al. described the identification of
ghrelin as an endogenous agonist for GHSR that potently stimulates GH
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starvation-like settings [2,3]. While binding of ghrelin to GHSR is
required for ghrelin action, GHSR signaling also occurs via a ghrelin-
independent, constitutive manner [3e7]. As first reported in 2003,
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Original Articlehuman GHSR dose-dependently increases signaling via the Gaq/
phospholipase C pathway, increasing inositol phosphate (IP) accu-
mulation and inducing cAMP response element-dependent activity [8].
These in vitro indications of high constitutive GHSR activity have been
extended to other signaling systems including reduced b-arrestin
recruitment and those involving voltage-gated CaV2.2 calcium chan-
nels, among others [9e14]. Indeed, transfection with GHSR increases
basal signaling above mock-transfected cells to approximately 50% of
GHSR’s maximal signaling capacity [13].
Of interest, studies with administered GHSR inverse agonists, which
are defined as such by their capacity to inhibit constitutive GHSR ac-
tivity, suggest physiologically significant effects of constitutive GHSR
activity. For example, infusion in rats of the high-potency GHSR inverse
agonist [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P [8] decreased
food intake and body weight [15]. Intrarenal infusion of the same
compound prevented hypertension in uninephrectomized Dahl salt-
sensitive rats fed high-fat diets [16]. Administration of the GHSR in-
verse agonist K-(D-1-Nal)-FwLL-NH2, but not administration of the
GHSR antagonists [D-Lys-3]-GHRP-6 or JMV2959, reduced compen-
satory hyperphagia following a 48 h fast and binge-like high-fat intake
in mice [17,18]. Administration of GHSR inverse agonists GHSR-IA1
and/or GHSR-IA2 reduced food intake and increased energy expen-
diture in lean C57BL/6N mice, reduced food intake, body weight, and
blood glucose in diet-induced obese C57BL/6J mice, and improved
oral glucose tolerance in Zucker diabetic fatty rats [19]. Additionally,
the GHSR inverse agonist PF-05190457 decreased postprandial blood
glucose and delayed gastric emptying in human subjects, although it
also blocked administered ghrelin-induced GH secretion [20]. This
latter finding is a reminder that most inverse agonists also act as
antagonists, and furthermore, that many pharmacologic GHSR ligands
exhibit differential functional signaling and downstream signaling bias
[12,21e23].
Also suggesting a potentially important physiological role for consti-
tutive GHSR activity, liver-enriched antimicrobial peptide-2 (LEAP2)
was recently identified as a second endogenous GHSR ligand, one with
both GHSR antagonist and inverse agonist activities [24e27]. As such,
LEAP2 not only blocks ghrelin-induced GHSR signaling in vitro, ghrelin-
induced membrane depolarization of arcuate NPY neurons, and
ghrelin-induced food intake and GH secretion, but also reduces
constitutive IP accumulation in GHSR-transfected cells and hyperpo-
larizes arcuate NPY neurons [24e27]. It has been proposed that
LEAP2’s actions as a GHSR antagonist and inverse agonist become
pronounced when its plasma levels increase, as occurs in obesity,
especially postprandially [24,26].
Notably, a naturally occurring GHSR mutation that impairs constitu-
tive GHSR activity was reported by Pantel et al. [28]. This GHSR-
A204E mutation, which was identified in two unrelated Moroccan
families, segregated with short stature in a dominant manner with a
penetrance of w70% [21,28]. In vitro studies revealed that the
GHSR-A204E mutant exhibited markedly reduced basal Gaq-medi-
ated signaling, a near total reduction in b-arrestin recruitment, and
resistance to the usual signaling effects of [D-Arg1, D-Phe5, D-Trp7,9,
Leu11]-substance P, all of which suggest lost constitutive GHSR ac-
tivity [14,21,28]. However, ghrelin binding and ghrelin-induced Gaq-
coupled signaling were unaltered in GHSR-A204E-transfected cells
[28]. Thus, the short stature associated with the GHSR-A204E mu-
tation was attributed to lost constitutive GHSR activity [21,28].
Interestingly, several family members carrying the GHSR-A204E
mutation were also overweight or obese [28], and another study
independently reported the GHSR-A204E mutation in an obese child
[29]. Other naturally occurring GHSR mutations causing decreased2 MOLECULAR METABOLISM 39 (2020) 101004  2020 The Author(s). Published by Elsevier GmbH. T
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described [21,29,30]. In the current study, we further investigated
the physiological significance of constitutive GHSR activity by intro-
ducing an A203E mutation (the mouse correlate of the previously
described human GHSR-A204E mutation) into the mouse GHSR
sequence.
2. MATERIALS AND METHODS
2.1. Signaling studies in COS-7 cells
In Copenhagen, COS-7 cells (ATCC, Wesel, Germany) were grown in
Dulbecco’s modified Eagle’s medium (DMEM) 1885 containing 10%
fetal bovine serum (FBS), 2 mM L-glutamine, and 1% penicillin/
streptomycin at 37 C in a 10% CO2 incubator. Cells seeded at a
density of 20,000 cells/well in a 96-well plate were transiently
transfected with 0.4 mg of pCMV-Tag2B plasmid (Stratagene, La
Jolla, CA, USA) DNA per well by calcium phosphate precipitation
using a method modified from [31]. The plasmids contained either
GHSR-WT or GHSR-A203E constructs, which were generated using
the PCR overlap extension method with Pfu polymerase (Promega,
Waltham, MA, USA) as previously described [14]. The constructs’
sequences were verified by DNA sequencing (Eurofins MWG Operon,
Ebersberg, Germany). Five h after transfection, the medium was
exchanged for growth medium (Dulbecco’s modified Eagle’s medium
(DMEM) 1885 containing 10% fetal bovine serum (FBS), 2 mM L-
glutamine, and 1% penicillin/streptomycin) containing 5 mL/mL of
Myo-[2e3H(N)]-inositol (PerkinElmer, Skovlunde, Denmark), and the
cells were incubated for 2 d. Signaling studies were conducted by
removing the medium, washing the cells once with 1x HBSS buffer,
and then incubating at 37 C in 100 mL HBSS buffer containing
10 mM LiCl) and a range of different ghrelin (Polypeptide, Inc., Hill-
erød, Denmark) concentrations. Aftera 90 min incubation, the cells
were placed on ice, lysed with ice-cold 10 mM formic acid for at least
30 min, transferred to 96-well plates containing SPA-YSI beads
(PerkinElmer), shaken at full speed on a plate shaker (PerkinElmer)
for at least 10 min, centrifuged for 5 min at 1500 rpm, and incubated
for 4 h at room temperature. IP3 accumulation was measured using a
Microbeta (PerkinElmer). For each replicate, the Emax values of the
GHSR-WT construct were normalized and set to 100% for further
analysis.
2.2. Whole-cell patch-clamp in HEK293T cells
In La Plata, HEK293T cells (kindly provided by Dr. Diane Lipscombe,
Brown University, Providence, RI, USA) were grown in DMEM (Gibco
Thermo Fisher Scientific, Waltham, MA, USA) containing 10% FBS
(Internegocios, Mercedes, Buenos Aires, Argentina). The cells were
transiently transfected with plasmids containing GHSR-WT or GHSR-
A203E and plasmids containing voltage-gated calcium channel
subunits CaV2.2 (Cacna1b, GenBank access #AF055477) with
auxiliary subunits CaVb3 (Cacnb3, GenBank access #M88751) and
CaVa2d1 (Cacna2d1, GenBank access #AF286488) using Lipofect-
amine 2000 (Invitrogen). CaV subunits were kindly provided by Dr.
Lipscombe and GHSR-WT was kindly provided by Dr. Jacky Marie,
University of Montpellier, Montpellier, France). The GHSR-A203E
construct was generated through directed mutagenesis of a mouse
GHSR (MC212500, OriGene, Rockville, MD, USA) containing plasmid
by Dr. Silvia Rodriguez at the IMBICE, La Plata. For experiments
lacking one or more plasmids, the cells were transfected with empty
plasmid pcDNA3.1 (þ) (Invitrogen) to maintain an equivalent total
cDNA amount in the transfection mix and an eGFP-containing plasmid
to identify transfected cells. After transfection, the cells were culturedhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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for 24 h, dispersed with 0.25 mg/mL trypsin, rinsed twice in DMEM,
and maintained at room temperature in DMEM for whole-cell patch-
clamp recordings. The internal pipette solution contained (in mM) 134
CsCl, 10 EGTA, 1 EDTA, 10 HEPES, and 4 MgATP (pH 7.2 with CsOH).
The external solution contained (in mM) 2 CaCl2, 1 MgCl2, 10 HEPES,
and 140 choline chloride (pH 7.4 with CsOH). The cells were main-
tained at100 mV to remove closed-state inactivation [32]. The test-
pulse protocol consisted of square pulses applied from 100
toþ10 mV every 10 s. Electrophysiological recordings were acquired
using an Axopatch 200 amplifier (Molecular Devices). Data were
sampled at 20 kHz and filtered at 10 kHz (3 dB) using PCLAMP8.2
software (Molecular Devices). Recording electrodes with resistances
between 2 and 5 MU were used filled with internal solution. Series
resistances less of 6 MU were admitted and compensated to 80%
with a 10 ms lag time. Current leak was subtracted online using a P/-
4 protocol. All of the recordings were obtained at room temperature
(23 C).
2.3. Generation of GHSR-A203E and GHSR-A203E-null mouse lines
The targeting construct used to generate our previously reported
GHSR-null mouse line [33], which contains a loxP-flanked transcrip-
tional blocking cassette (TBC) within an intron located downstream of
the transcriptional start site and upstream of the translational start site
of the mouse Ghsr gene surrounded by Ghsr homology arms, was
mutated using site-directed mutagenesis (QuickChange II XL Site-
Directed Mutagenesis Kit, Agilent, Santa Clara, CA, USA). Plasmid
containing the GHSR-null targeting construct was amplified by PCR
using primers containing the desired mutation (underlined) at the
codon for amino acid 203 (50-GCCACCGAGTTCGAAGTGCGCTCTGGGC-
30 and its reverse complement) digested with DpnI and transformed
into One Shot Top10 Competent Cells (Agilent). DNA from the resulting
clones was sequenced to confirm the successful introduction of only
the desired mutation. The resulting GHSR-A203E plasmid was sub-
mitted to the UT Southwestern Medical Center Transgenic Core Facility
for gene targeting. Correctly targeted ES cell clones were identified by
Southern blotting and PCR analyses as conducted originally for the
GHSR-null line [1]. Two ES cell clones were sequenced to confirm the
presence of the desired mutation and then sent for blastocyst injection.
Germline transmission was established for both clones and the
resulting mice were backcrossed once to C57Bl/6N. GHSR-A203E-null
mice (harboring 2 copies of the Ghsr allele containing the loxP-flanked
TBCþ the A203E mutation) and their littermates, which included wild-
type mice (harboring 2 copies of the wild-type Ghsr allele) and het-
erozygotes, were viable and born with the expected Mendelian dis-
tribution upon mating of heterozygotes, as confirmed by both Southern
blotting analysis of genomic DNA and sequencing (data not shown).
Mice heterozygous for the GHSR-A203E-null allele from the initial
backcross to C57Bl/6N were crossed to Zona Pellucida 3 (ZP3-cre)
mice [34] to generate female breeders with one copy of the GHSR-
A203E-null allele and one copy of the ZP3-cre transgene. As the
ZP3-cre removed the TBC from the ova of the female breeders, when
crossed to C57Bl/6N males, they resulted in progeny with one copy of
the GHSR-A203E allele (the GHSR-A203E-null allele minus one loxP
site and the TBC) and one copy of the ZP3-cre allele. Subsequent
crosses to C57Bl/6N were conducted to remove ZP3-cre. Finally, mice
heterozygous for the GHSR-A203E allele were crossed to each other to
generate GHSR-A203E mice (harboring 2 copies of the Ghsr allele
containing the A203E mutation) and their littermates, which included
wild-type mice and heterozygotes. The study mice were derived from
heterozygotes that had been backcrossed onto C57Bl/6N for 7
generations.MOLECULAR METABOLISM 39 (2020) 101004  2020 The Author(s). Published by Elsevier GmbH. This is an open
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Ex vivo studies were conducted using tissues taken from mice housed
in La Plata (Figure 3) and Dallas (Figure 4). In vivo studies were
conducted in Dallas (Figures 5, 7A, and 8) and Copenhagen (Figure 2B,
C, 6, and 7BeG). The mice were housed at room temperature (Dallas:
21.5e22.5 C; Copenhagen: 22 C  2 C; La Plata: 23 C) using a
12 h lightedark cycle and provided ad libitum access to water and
standard chow [Dallas: 2016 Teklad Global 16% Protein Rodent Diet
(Envigo, Indianapolis, IN, USA); Copenhagen: Altromin 1314 (extruded
form, Altromin GmbH & Co. KG, Im Seelenkamp, Germany); and La
Plata: Gepsa Feeds (Grupo Pilar, Pilar, Argentina)], except as noted.
The animal procedures were approved by the Institutional Animal Care
and Use Committee of UT Southwestern Medical Center, the Danish
Working Environment Authority at University of Copenhagen, or the
Institutional Animal Care and Use Committee of the IMBICE.
2.5. Whole-cell patch-clamp in cultured hypothalamic neurons
In La Plata, hypothalamic neuronal cultures were derived from
GHSR-A203E, GHSR-A203E-null, and wild-type mice at embryonic
days 16e18 as described in [35]. Hypothalami were removed from
embryonic brains, placed in sterile Hanks’ solution, and rinsed twice.
Cells were dissociated with 0.25 mg/mL trypsin (Microvet, Buenos
Aires, Argentina) at 37 C for 20 min and then 300 mL fetal bovine
serum (FBS, Internegocios) and 0.28 mg/mL deoxyribonuclease I
(SigmaeAldrich, Buenos Aires) were added. The cells were me-
chanically dissociated using several glass pipettes with consecu-
tively smaller diameter tips. Overall, w70,000 cells were plated on
12 mm diameter glass coverslips treated with poly-L-lysine (Sigmae
Aldrich) and laid over 24-well plates. The cells were incubated at
37 C in a 95% air/5% CO2 atmosphere with DMEM/F12 (Microvet)
1:1 medium supplemented with B27 supplement (1:50, Gibco,
Thermo Fisher Scientific), 10% FBS, 0.25% glucose, 2 mM gluta-
mine (Gibco), 3.3 mg/mL insulin (Novo Nordisk Pharmaceutical In-
dustries, Inc., Buenos Aires, Argentina), 40 mg/mL gentamicin
sulfate salt (Richet, Buenos Aires, Argentina), and 1% vitamin so-
lution (Microvet). On the fourth day in culture, half of the incubating
medium was replaced with fresh medium containing cytosine b-D-
arabinofuranoside (SigmaeAldrich) to reach a final concentration of
5 mM.
Barium currents of primary neuronal cultures were obtained following
7e15 days of culture. The neurons were patched in voltage-clamp
whole-cell mode at a holding potential of 80 mV, applying squared
test pulses to 0 mV for 20 ms every 10 s [36]. The internal pipette
solution contained (mM) 134 CsCl, 10 EGTA, 1 EDTA, 10 HEPES, and 4
MgATP, pH 7.2 with CsOH. Neurons were bathed with high-sodium
external solution containing (mM) 135 NaCl, 4.7 KCl, 1.2 MgCl2, 2.5
CaCl2, 10 HEPES, and 10 glucose pH 7.4 with NaOH. After obtaining
the whole-cell configuration, CaV currents were recorded after
replacing the external solution with a high-barium solution containing
(mM) 10 BaCl2, 110 choline chloride, 20 tetraethylammonium chloride,
1 MgCl2, 10 HEPES, 10 glucose, and 0.001 tetrodotoxin (TTX; Sigmae
Aldrich) pH 7.4 with CsOH. Electrophysiological recordings were ac-
quired as described in Section 2.2.
2.6. Whole-cell patch-clamp in brain slices
In Dallas, GHSR-A203E mice were crossed to NPY-hrGFP mice [kindly
provided by Dr. Joel Elmquist (UT Southwestern Medical Center [37]) to
generate GHSR-A203E and wild-type littermates with humanized
Renilla reniformis green fluorescent protein-labeled NPY neurons.
Recordings from NPY-hrGFP neurons within 250 mm thick coronal
hypothalamic slice preparations from 8- to 12-week-old male miceaccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 3
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Figure 1: In vitro studies comparing signaling by GHSR-WT vs GHSR-A203E mutant. (A) Basal and ghrelin-induced IP3 accumulation in COS-7 cells expressing GHSR-WT
(EC50 ¼ 7.0  0.8  109 M; Emax ¼ 99.3%) or GHSR-A203E (EC50 ¼ 1.7  0.1  109 M; Emax ¼ 88.7%) (n ¼ 5). Data were analyzed by an unpaired Student’s t-test
for 0, 106, and 105 M concentrations of ghrelin. (B) Representative traces of CaV current and (C) mean CaV current values from HEK293T cells co-expressing CaV2.2 and its
auxiliary subunits (CaVa2d1 and CaVb3) together with empty plasmid (control, n ¼ 16) or GHSR-A203E (n ¼ 4) or GHSR-WT (n ¼ 4). Data were analyzed by KruskaleWallis ANOVA
followed by Dunn’s post hoc analysis. (D) Normalized representative traces of CaV current and (E) mean CaV current percentage of inhibition by ghrelin of HEK293T cells co-
expressing CaV2.2 and its auxiliary subunits (CaVa2d1 and CaVb3) together with GHSR-A203E (n ¼ 5) or GHSR-WT (n ¼ 5), in the absence and presence of ghrelin
(500 nM). Data were analyzed by unpaired Student’s t-test. *P < 0.05, ****P < 0.0001, and n.s. ¼ non-significant.
Original Article
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Figure 2: Generation of the GHSR-A203E and GHSR-A203E-null mouse models. (A) Schematic diagram of the derivation of the GHSR-A203E and GHSR-A203E-null mouse models
by homologous recombination. (B) Hypothalamic expression of food intake- and body weight-related transcripts in 66-week-old mice (n ¼ 7e9 per group). (C) Pituitary expression
of GH secretion-related transcripts in 14-week-old males (n ¼ 3 per group). Data were analyzed by unpaired Student’s t-test. #P ¼ 0.051.and data analysis were conducted as in [26,38,39]. The pipette so-
lution for whole-cell recording contained (mmol/L) 120 K-gluconate, 10
KCl, 10 HEPES, 5 EGTA, 1 CaCl2, 1 MgCl2, 2 MgATP, and either 0.03
Alexa Fluor 594 or 0.03 Alexa Fluor 350 hydrazide dye (pH 7.3). Epi-
fluorescence was briefly used to target fluorescent cells, at which time
the light source was switched to infrared differential interference
contrast imaging to obtain the whole-cell recording (Zeiss Axioskop
FS2 Plus equipped with a fixed stage and a QuantEM:512SC electron-
multiplying charge-coupled device camera). Electrophysiological sig-
nals were recorded using an Axopatch 700B amplifier (Molecular
Devices, San Jose, CA, USA) low-pass filtered at 2e5 kHz and
analyzed offline on a PC with pCLAMP programs (Molecular Devices).
Recording electrodes had resistances of 2.5e5 MU when filled with
the K-gluconate internal solution. The input resistance was assessed
by measuring the voltage deflection at the end of the response to a
hyperpolarizing rectangular current pulse step (400 ms of10 to50
pA). Ghrelin (rat; 100 nmol/L, Innovagen, Lund; Catalog #SP-GHRL-1)
was added to the oxygenated ACSF bathing the hypothalamic slices for
specific experiments. Solutions containing ghrelin were typically
perfused for 2e4 min. A drug effect was required to be temporally
associated with peptide application, and the response had to be stable
within a few minutes. A neuron was considered depolarized or
hyperpolarized if a change in its membrane potential was at least 2 mV
in amplitude.MOLECULAR METABOLISM 39 (2020) 101004  2020 The Author(s). Published by Elsevier GmbH. This is an open
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Four-week-old mice were individually housed one week after weaning.
In Dallas (Figure 5), body weight and food intake were monitored
weekly at 9:00 am for 21 weeks. The cumulative feed efficiency was
calculated by comparing the body weight at each weekly time point to
the starting body weight and then dividing this body weight gain value
by the energy content of the chow consumed over the same duration.
Nose-to-anus body lengths of female mice were assessed by placing
25-week-old mice anesthetized with isoflurane prone on a ruler. In
Copenhagen (Figure 6), body weights were measured at various time
points between the ages of 21e66 weeks. Body lengths were assessed
as previously described in anesthetized mice at 3 different time points.
At 66 weeks of age, femurs and hypothalami were extracted from
euthanized mice. Femur lengths were measured using calipers.
2.8. Administered ghrelin-induced food intake
In Dallas (Figure 7A), following the long-term feeding study, the 25-
week-old male mice were handled for 3 days to acclimatize them,
after which they were administered s.c. injections of saline, and then
0.1 mg/kg ghrelin 2 d later, followed by 1.0 mg/kg ghrelin 2 d after-
ward at 9:30 am. Two h intake of a standard chow pellet placed on the
cage floor was determined after each injection. At 26 weeks of age, the
males were anesthetized and nose-to-anus body lengths assessed as
previously described. Femurs extracted from euthanized 26-week-oldaccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 5
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Figure 3: Ex vivo studies comparing native calcium current in cultured hypothalamic neurons from GHSR-A203E-null, wild-type, and GHSR-A203E mice. (A) Representative traces
of barium currents (IBa) and (B) mean IBa current values from cultured hypothalamic neurons from GHSR-A203E-null (n ¼ 16), wild-type (including a combination of wild-type
littermates of both the GHSR-A203E-null and GHSR-A203E lines; n ¼ 10), and GHSR-A203E (n ¼ 25) mice. (C) Normalized representative traces of IBa currents and (D)
mean IBa current percentage inhibition by ghrelin of hypothalamic neurons from GHSR-A203E-null (n ¼ 5), wild-type (n ¼ 4), and GHSR-A203E mice (n ¼ 11) in the absence and
presence of ghrelin (500 nM). Data were analyzed by KruskaleWallis ANOVA with Dunn’s post hoc analysis. *P < 0.05, ***P < 0.001, ****P < 0.0001, and n.s. ¼ non-
significant.
Original Articlemice were measured using calipers. In Copenhagen (Figure 7BeC), a
separate cohort of 9e12-week-old male mice was individually housed
within a 16-chamber indirect calorimetry system (PhenoMaster; TSE
Systems, Bad Homburg, Germany) after 4 d in an identical set of
acclimation cages. The mice received s.c. injections of either ghrelin
(Polypeptide, Inc., Hillerød, Denmark) (2 mg/kg vs saline in a crossover
fashion between 10.30 and 11.00 am, with a 2 d intervening period).
Food intake and the respiratory exchange ratio (RER) were determined
2 h after the injections.
2.9. Administered ghrelin-induced GH secretion
In Copenhagen, ghrelin- and GHRH-induced GH secretion were
assessed in a new cohort of male mice aged 7 and 10 weeks,
respectively. Fifteen minutes after anesthesia with pentobarbital (i.p.
50 mg/kg body weight), ghrelin (0.5 mg/kg i.p.; Polypeptide, Inc.) or
GHRH (0.5 mg/kg i.p.; Phoenix Pharmaceuticals, Karlsruhe) were6 MOLECULAR METABOLISM 39 (2020) 101004  2020 The Author(s). Published by Elsevier GmbH. T
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For personal use only. No other uses without permission. Cinjected. Blood was sampled from the orbital sinus before and 5 min
after injections, as previously described [40,41].
2.10. 7-d 60% caloric restriction protocol
In Dallas, 7-week-old male mice were individually housed for 1 week
during which daily food intake was measured for 3 successive days to
determine the mean usual daily intake for each mouse. The mice were
weighed and blood glucose determined from tail nicks using a Contour
Next blood glucose monitoring system (Bayer, Mishawaka, IN, USA)
daily 30 min before lights out. The mice were provided access to 40%
of their usual daily calories in the form of their usual diet for 7 d
beginning 15 min before lights out as previously described [42]. Body
composition was determined using an EchoMRI (Echo Medical Sys-
tems, Houston, TX, USA) at the start of the experiment and again on
days 4 and 6. Blood for GH and ghrelin determinations was collected
on days 0, 5, and 7 by quick superficial temporal vein (submandibular)his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 4: Ex vivo studies comparing electrophysiological properties of arcuate NPY neurons from wild-type vs GHSR-A203E littermates. (A) Representative NPY-GFP neurons from
a wild-type mouse on an NPY-GFP background under (i) bright-field illumination and (ii) FITC (GFP) illumination. Complete dialysis of Alexa Fluor 350 from the intracellular pipette is
shown in (iii). A merged image of the targeted NPY neuron is shown in (iv). Arrow indicates the targeted cell. Scale bar ¼ 50 mm. (B) Representative NPY-GFP neuron from a GHSR-
A203E mouse on an NPY-GFP background under (i) bright-field illumination and (ii) FITC (GFP) illumination. Complete dialysis of Alexa Fluor 594 from the intracellular pipette is
shown in (iii). A merged image of the targeted NPY neuron is shown in (iv). Arrow indicates the targeted cell. Scale bars ¼ 50 mm. (C and D) Representative current-clamp
recordings of NPY neurons from (C) wild-type and (D) GHSR-A203E mice demonstrating resting membrane potentials and depolarization upon addition of ghrelin (100 nM). (E)
Change in membrane potential in NPY neurons from wild-type or GHSR-A203E mice in response to ghrelin (100 nM) or vehicle (ACSF). Data were analyzed by 2-way ANOVA
followed by a Tukey post hoc analysis. **P < 0.01. (FeG) Linear regression analyses of currentevoltage (IeV) plots of (F) wild-type (G) and GHSR-A203E mice.
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Figure 5: Metabolic phenotype of wild-type and GHSR-A203E littermates. (AeB) Body weight, (CeD) % weight gain, (EeF) food intake, (GeH) food intake/body weight, and (IeJ)
cumulative feed efficiency in male (A, C, E, G, and I) and female (B, D, F, H, and J) wild-type (n ¼ 7e9) and GHSR-A203E (n ¼ 10e12) littermates. (KeL) Nose-anus body lengths
in 26-week-old male (K) (n ¼ 8e10) and 25-week-old female (L) (n ¼ 9e12) mice. (M) Femur length in 26-week-old male (n ¼ 8e10) mice. Data were analyzed by (AeJ)
repeated measures 2-way ANOVA followed by a Tukey post hoc analysis or (KeM) Student’s unpaired t-test. *P < 0.05, ***P < 0.001, ****P < 0.0001, #0.05  P < 0.1, and
n.s. ¼ non-significant.
Original Article
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Figure 6: Metabolic effects of the GHSR-A203E mutation in older mice. (A) Body weights of male mice aged 21e66 weeks of age (n ¼ 7e10). (B) Body lengths of male mice at 3
different ages (n ¼ 7e9). (C) Femur lengths of male mice at 65e66 weeks of age (n ¼ 6e8). Data were analyzed by (AeB) repeated measures 2-way ANOVA followed by Sidak’s
multiple comparison post hoc analysis or by (C) an unpaired Student’s t-test. *P < 0.05, ****P < 0.0001.
Figure 7: In vivo effects of administered ghrelin in wild-type and GHSR-A203E littermates. (A) Ghrelin [0 (saline), 0.1, and 1 mg/kg s.c.)-induced 2 h food intake in 25-week-old
male mice (n ¼ 7e10). (BeC) Ghrelin (2 mg/kg s.c.)-induced (B) 2 h food intake and (C) RER (2 h after ghrelin administration) in 9e12-week-old male mice (n ¼ 6e7). (D) Ghrelin
(0.5 mg/kg i.p.)-induced GH secretion in 7-week-old mice (n ¼ 3e4). (E) GHRH (0.5 mg/kg i.p.)-induced GH secretion in 10-week-old mice (n ¼ 7). (F) Plasma IGF-1 (n ¼ 6e8)
and (G) pituitary GH content (n ¼ 5e8) in 66-week-old mice. Data were analyzed by (A) a 2-way ANOVA followed by a Tukey post hoc analysis, (BeE) a 2-way repeated measures
ANOVA followed by a Sidak’s multiple comparison post hoc analysis, or (FeG) an unpaired Student’s t-test. *P < 0.05, **P < 0.01, ****P < 0.0001, #0.05  P < 0.1, and
n.s. ¼ non-significant.
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Figure 8: Effects of a 7-d severe (60%) caloric restriction protocol. (A) Body weights, (B) % fat mass, (C) % lean mass (n ¼ 9e20), (D) plasma GH levels (n ¼ 7e10), (E) plasma
ghrelin (n ¼ 7e13), (F) blood glucose (n ¼ 9e20), and (G) % survival (9/9 wild-type mice and 17/20 GHSR-A203E mice) over the 7-d course of daily access to 40% of usual daily
calories. (AeF) Data were analyzed by 2-way ANOVA followed by Tukey post hoc analyses. (G) Survival curves were calculated by the KaplaneMeier method, with comparisons
determined using the ManteleCox log-rank test. *P < 0.05, ****P < 0.0001, and n.s. ¼ non-significant.
Original Articlebleed into ice-cold EDTA-coated microtubes immediately after
assessing blood glucose.
2.11. Hormone levels
For plasma ghrelin levels, p-hydroxymercuribenzoic acid was added
(final concentration 1 mM) to EDTA-treated blood, tubes were
centrifuged, and HCl was added (final concentration 0.1 N) prior to
storage at 80 C. No further processing of the EDTA-treated blood
was performed prior to GH or IGF-1 determinations. To measure pi-
tuitary GH levels, pituitaries were lysed using RIPA lysis buffer [1%
Triton X-100, 150 mM NaCl, 10 mM TriseHCl (pH 7.5), 1 mM EDTA,
1% NP-40, and complete mini Protease Inhibitor Cocktail; Roche,
Mannheim, Germany] and homogenized using a Qiagen TissueLyser II
(Germantown). Ghrelin, GH, and IGF-1 levels were measured using
commercial ELISA kits (EZRGRA-90K, EMD Millipore, Billerica, MA,
USA; EZRMGH-45K, EMD Millipore; 22-IG1MS-E01, ALPCO, Reutlin-
gen, Germany). The endpoint calorimetric assays were conducted
using a PowerWave XS Microplate spectrophotometer and KC4 Junior10 MOLECULAR METABOLISM 39 (2020) 101004  2020 The Author(s). Published by Elsevier GmbH. T
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ware version 5.40R2 and Mars software version 3.3 (BMG LabTech,
Ortenberg, Germany).
2.12. Quantitative PCR
Hypothalamic RNA (from 66-week-old mice as previously described)
and pituitary RNA (from 14-week-old mice) was extracted using an
RNeasy Micro Kit (Qiagen). RNA concentrations were measured using a
NanoDrop 2000 Spectrophotometer (Thermo Fisher Scientific). RNA
samples were reverse transcribed to cDNA using SuperScript III
Reverse Transcriptase (Thermo Fisher Scientific). The mix was incu-
bated at 25 C for 5 min, 50 C for 60 min, and 70 C for 15 min using
Eppendorf Vapo-Protect Mastercycler. The cDNA samples were diluted
20x in sterile water and stored at 20 C until further analysis. The
diluted cDNA samples were mixed with PrecisionPLUS qPCR Master
Mix (Primerdesign Ltd., Southampton, UK) according to the manu-
facturer’s description. The samples were run using a LightCycler 480
Instrument II (Roche, Basel, Switzerland), LightCycler 480 softwarehis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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version 1.5.1.62, and the deltaedelta Ct method using GAPDH as a
housekeeping gene to quantify the mRNA expression.
The following PCR primers designed with Primer 3 (http://bioinfo.ut.ee/
primer3-0.4.0/) were used: GHSR (50-AAGATGCTTGCTGTGGTGGT-30,
50-AAAGGACACCAGGTTGCAGT-30), GH (50-CTACAAAGAGTTCGAGCGTG




TGA-30), NPY (50-TGGACTGACCCTCGCTCTAT-30, 50-TGTCTCAGGGCT
GGATCTCT-30), POMC (50-AGAGAGCTGCCTTTCCGCGAC-30, 50-GCAG-
GAGGGCCAGCAACAGG-30), GHRH (50-CCAATTATATGCCCGCAAAC-30,
50-GCTGAAAGCTTCATCCTTGG-30), and GAPDH (50-AAGGGCTCAT-
GACCACAGTC-30, 50-GGATGCAGGGATGATGTTCT-30).
2.13. Statistical analyses
Analyses were conducted using the tests indicated in the figure leg-
ends via GraphPad Prism 6.0 (Graph-Pad Software, San Diego, CA,
USA) or NCSS 2007 (NCSS Statistical Software, Kaysville, UT, USA). All
of the data were first subjected to Grubbs’ outlier test. Data are
expressed as mean  SEM. P values < 0.05 were considered sta-
tistically significant, and values 0.05  P < 0.1 were considered
evidence of statistical trends.
3. RESULTS
3.1. The GHSR-A203E mutant lacks constitutive GHSR activity but
retains ghrelin-dependent GHSR activity in heterologous expression
systems
We measured the IP3 accumulation in COS-7 cells transiently trans-
fected with constructs encoding mouse wild-type GHSR (GHSR-WT) or
GHSR-A203E. As shown previously for the corresponding human
constructs [14], in the absence of ghrelin, cells expressing GHSR-
A203E accumulated less basal IP3 than cells expressing GHSR-WT
(GHSR-A203E: 3.7% vs GHSR-WT: 44.3% of the maximal response
to ghrelin; Figure 1A). Ghrelin dose-dependently increased IP3 accu-
mulation in both groups, with no significant differences observed at
106 M or 105 M ghrelin (Figure 1A). We recorded the calcium
currents in HEK293T cells expressing the CaV2.2 calcium channel
complex alone (control) or with GHSR-WT vs GHSR-A203E. As shown
previously for human GHSR-WT [10], in the absence of ghrelin, mouse
GHSR-WT reduced CaV2.2 current density whereas GHSR-A203E did
not (Figure 1B and C). Ghrelin inhibited CaV2.2 current in cells co-
expressing either GHSR-WT or GHSR-A203E (Figure 1D and E).
These in vitro studies suggest that the A203E mutation eliminates
constitutive GHSR activity but still permits ghrelin-dependent GHSR
signaling.
3.2. A newly generated novel GHSR-A203E mouse model
expresses GHSR-A203E in place of GHSR-WT
The remaining studies utilized a novel mouse model expressing
GHSR-A203E instead of GHSR-WT. To generate these mice, we
inserted a loxP-flanked transcriptional blocking cassette (TBC) into
an intron located downstream of the transcriptional start site and
upstream of the translational start site of the mouse Ghsr gene.
Additionally, we mutated the codon for alanine at position 203 to
encode glutamate. Mice harboring two copies of the GHSR-A203E
gene with the upstream loxP-flanked TBC are hereafter referred to
as GHSR-A203E-null mice; these mice express neither GHSR-WT nor
GHSR-A023E. These mice were crossed with Zp3-cre mice [34] to
remove the TBC. Mice harboring two copies of the GHSR-A203EMOLECULAR METABOLISM 39 (2020) 101004  2020 The Author(s). Published by Elsevier GmbH. This is an open
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A203E mice; these mice expressed GHSR-A203E instead of GHSR-
WT (Figure 2A).
RT-PCR analysis of hypothalamic and pituitary glands confirmed
similar levels of mRNA encoding GHSR-A203E in the GHSR-A203E
mice as mRNA encoding GHSR-WT in the wild-type littermates
(Figure 2B and C). RT-PCR analysis of a selected group of food intake-
and body weight-related transcripts and GH secretion-related tran-
scripts revealed no effect of the GHSR-A203E mutation on mRNA levels
of NPY or uncoupling protein-2 (UCP2) in hypothalami or growth
hormone-releasing hormone receptor (GHRHR) or somatostatin re-
ceptors 2 or 5 (SSTR2 or SSTR5) in pituitaries (Figure 2B and C).
Hypothalamic pro-opiomelanocortin (POMC) mRNA expression
increased while pituitary GH mRNA expression decreased in the GHSR-
A203E mice (Figure 2B and C). Thus, GHSR-A203E mice express
GHSR-A203E at levels similar to those of wild-type GHSR in wild-type
mice. Furthermore, the GHSR-A203E mutation alters hypothalamic
POMC and pituitary GH mRNA expression, without effects on a selected
set of related transcripts.
3.3. Cultured hypothalamic neurons from GHSR-A203E mice lack
constitutive GHSR activity but retain ghrelin-dependent GHSR activity
We assessed native calcium currents in cultured mediobasal hypo-
thalamic neurons from the GHSR-A203E mice, GHSR-A203E-null mice,
and wild-type littermates by measuring barium current densities at
baseline and in response to ghrelin. This region contains a dense
population of arcuate NPY neurons, which represent a well-established
site of GHSR expression [43,44]. The barium current densities in
GHSR-A203E neurons were similar to those in GHSR-A203E-null
neurons but significantly increased compared to those in wild-type
neurons (Figure 3A and B). This increased calcium current within
GHSR-A203E-null neurons was similar to that observed in the related
GHSR-null model of GHSR deficiency [35]. Ghrelin inhibited native
calcium current in hypothalamic neurons from both wild-type and
GHSR-A203E mice, although it had no effect on neurons from GHSR-
A203E-null mice (Figure 3C and D). Thus, the substitution of GHSR-
A203E for wild-type GHSR in hypothalamic neurons that normally
express GHSR increased native calcium current (similar to the effect of
GHSR deletion) but maintained the capacity to inhibit calcium current in
response to applied ghrelin (similar to the effect of ghrelin in neurons
from the wild-type mice).
3.4. Arcuate hypothalamic NPY neurons harboring the GHSR-
A203E mutation exhibit hyperpolarized membrane potentials yet
retain ghrelin responsivity
We conducted whole-cell patch-clamp recordings on two sets of
hrGFP-labeled arcuate NPY neurons in brain slices from the wild-type
and GHSR-A203E littermates (Figure 4A and B). GHSR-expressing
arcuate NPY neurons depolarized upon ghrelin exposure [43,44].
The first set included 39 wild-type and 38 GHSR-A203E neurons. The
GHSR-A203E neurons were hyperpolarized compared to the wild-type
neurons (wild-type mice: resting membrane
potential ¼ 40  1.1 mV, input resistance 1.3  0.1 GU, and
whole-cell capacitance 11.3  0.4 pF vs GHSR-A203E mice: resting
membrane potential¼46 0.7 mV, input resistance 1.3 0.1 GU,
and whole-cell capacitance 11.5 0.5 pF). The second set was tested
for ghrelin-induced changes and included 20 wild-type and 15 GHSR-
A203E neurons. Ghrelin depolarized 40% of arcuate NPY neurons from
both wild-type and GHSR-A203E littermates (Figure 4CeE). The sec-
ond set’s ghrelin-responsive neurons were hyperpolarized at baseline
in the GHSR-A203E mice compared to wild-type mice (wild-type mice:access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 11
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Original Articleresting membrane potential ¼ 45  1.3 mV, input resistance
1.3  0.1 GU, and whole-cell capacitance 12.6  0.9 pF vs GHSR-
A203E mice: resting membrane potential ¼ 49  2.2 mV, input
resistance 1.2  0.1 GU, and whole-cell capacitance 11.0  1.0 pF).
The lower resting membrane potential in the ghrelin-responsive GHSR-
A203E neurons likely contributed to their enhanced ghrelin-induced
change in membrane potential (Figure 4E). The mean ghrelin-
induced action potential frequencies in the GHSR-A203E neurons vs
wild-type neurons were similar (data not shown). Thus, constitutive
GHSR activity contributed to a native depolarizing conductance in the
arcuate NPY neurons. Also, ghrelin depolarized the same percentage of
arcuate NPY neurons in the GHSR-A203E mice as in the wild-type
littermates.
Rectangular current steps (50 pA at 400 ms) were applied to the
plasma membranes of the arcuate NPY neurons to obtain currente
voltage (IeV) plots. The depolarization was concomitant with a
decrease in input resistance (wild-type mice: 38.5%, n ¼ 3, and
1.3  0.2 GU for ACSF control; 0.8  0.1 GU for ghrelin, Figure 4F vs
GHSR-A203E mice: 35.7%, n¼ 3, and 1.4 0.1 GU for ACSF control;
and 0.9 0.1 GU for ghrelin, Figure 4G). Subsequent linear regression
analysis revealed the reversal potential of the ghrelin-induced depo-
larization was23 2.7 mV in the wild-type mice and20 4.7 mV
in the GHSR-A203E mice (Figure 4F and G). This suggests that a
putative non-selective cation conductance may have been involved in
the ghrelin-induced depolarization of the arcuate NPY neurons [45e
47].
3.5. GHSR-A203E mice develop reduced body weight and body
length when aged
We monitored the weekly body weights and food intake of individually
housed male and female GHSR-A203E and wild-type littermates with
ad libitum access to regular chow for 21 weeks beginning at 4 weeks
of age. No genotype-dependent differences in body weights were
observed over the course of the study (Figure 5A and B), although the
GHSR-A203E mice gained slightly less body weight (Figure 5C and D).
Weekly food intake over the course of the study was slightly greater in
the GHSR-A203E mice (Figures 5EeH). Cumulative feed efficiency
(defined as body weight gain per kilocalories of food consumed) was
slightly lower over the course of the study in male GHSR-A203E mice
but not females (Figure 5I and J). Body lengths (Figures 5K and L) and
femur lengths (Figure 5M) at the end of the 21-week study were
genotype-independent.
We also monitored the weekly body weights in a second cohort of
individually housed male GHSR-A203E and wild-type littermates with
ad libitum access to regular chow from 21-22 weeks of age until 65e
66 weeks of age. Although the starting body weights of the two ge-
notypes had no statistically significant differences, they gradually
diverged, leading to lower body weights for the GHSR-A203E mice
(Figure 6A). Similarly, although the body lengths of the two genotypes
had no statistically significant differences at 21e22 or 32e33 weeks
of age, by 65e66 weeks of age, the GHSR-A203E mice had shorter
body lengths (Figure 6B). The femur lengths of the 65e66 week old
GHSR-A203E mice were also shorter than those of their wild-type
littermates (Figure 6C).
Thus, while the GHSR-A203E mutation did not affect body weight, body
length, or femur length in a statistically significant manner in the first
w6 months of life, it was associated with decreased body weight,
body length, and femur length in mice aged>1 year. This was despite
slightly increased food intake in younger GHSR-A203E mice, albeit
younger male mice also gained slightly less weight per food
consumed.12 MOLECULAR METABOLISM 39 (2020) 101004  2020 The Author(s). Published by Elsevier GmbH. T
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ghrelin are blunted in GHSR-A203E mice
We assessed the acute food intake responses to administered ghrelin.
In a first set of mice (25-week-old male GHSR-A203E and wild-type
littermates individually housed in their home cages), ghrelin dose-
dependently increased 2 h food intake over that induced by saline in
the wild-type mice but not in their GHSR-A203E littermates (Figure 7A).
A similar observation was made for ghrelin using a single, higher dose
in a second set of mice (9-12-week-old male GHSR-A203E and wild-
type littermates individually housed in metabolic chambers)
(Figure 7B). The corresponding respiratory exchange ratio (RER) values
increased in the wild-type mice administered ghrelin but not in the
GHSR-A203E mice (Figure 7C).
We also assessed GH secretion in response to administered ghrelin in
the GHSR-A203E mice and their wild-type littermates. Whereas ghrelin
markedly increased plasma GH in the wild-type mice compared to
saline, its GH secretagogue efficacy was dramatically reduced
(although still present) in the GHSR-A203E mice (Figure 7D). In
contrast, GHRH, which increases GH release in a GHSR-independent
manner, increased the plasma GH levels in both the wild-type and
GHSR-A203E mice (Figure 7E).
We also measured plasma IGF-1 and pituitary GH content from the
previously described cohort of 65e66-week-old GHSR-A203E and
wild-type littermates. Following an overnight fast, plasma IGF-1 was
lower while pituitary GH content was higher in the GHSR-A203E mice
(Figure 7F and G).
These data suggest that the GHSR-A203E mice were resistant to the
usual acute orexigenic and GH secretagogue actions of administered
ghrelin. Also, seemingly coinciding with the decreased body length and
femur length in the aged GHSR-A203E mice, the plasma levels of the
downstream GH effector IGF-1 were lower although the pituitary GH
content was higher, suggesting a possible defect in GH release and an
ensuing decrease in IGF-1 recruitment in the GHSR-A203E mice.
3.7. GHSR-A203E mice submitted to a caloric restriction protocol
exhibit a markedly blunted GH response and an exaggerated drop in
blood glucose
We submitted the GHSR-A203E and wild-type littermates to a week-
long, severe caloric restriction protocol in which the mice were pro-
vided access to only 40% of their usual daily calories. This protocol
induced progressive elevations in plasma GH in the wild-type mice but
not in the ghrelin-knockout or ghrelin O-acyltransferase-knockout
mice [48,49]. These increases in GH help prevent the development of
life-threatening hypoglycemia that is otherwise observed in mice
lacking ghrelin, ghrelin O-acyltransferase, GHSR, ghrelin cell b1-
adrenergic receptors, or hepatic GH receptors, mice lacking ghrelin
cells, and mice overexpressing LEAP2 [24,42,48e53]. Over the course
of the 7-d regimen, no genotype-dependent differences in body weight
or body composition were observed (Figure 8AeC). Plasma GH
increased only in the wild-type mice, plasma ghrelin increased in a
genotype-independent manner, and a more precipitous decrease in
blood glucose was noted in the GHSR-A203E mice (Figure 7DeF).
Additionally, although not statistically significant, a genotype-
dependent difference in survival was noted, and 3 of 20 of the
GHSR-A203E mice died whereas none of the 9 wild-type littermates
died (Figure 7G).
4. DISCUSSION
In the current study, we used in vitro, ex vivo, and in vivo methods to
assess the physiological significance of constitutive GHSR activity. Thishis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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study was based on published work using in vitro heterologous cell
expression systems, which suggested that the naturally occurring
GHSR-A204E mutation associated with short stature in humans im-
pairs constitutive (ghrelin-independent) GHSR activity while retaining
ghrelin-dependent GHSR activity. For the current study, we used the
mouse GHSR-A203E correlate of the human GHSR-A204E mutation.
When comparing the phenotype of the GHSR-A203E mice to that of
human carriers of the GHSR-A204E mutation, similarities in body
length and GH deficiency were observed. The human GHSR-A204E
mutation is associated with a high penetrance of short stature,
which might be assumed to result from impaired GH secretion due to
the mutant GHSR [21,28]. Such was the case in two of the four GHSR-
A204E carriers with short stature in whom GH and IGF-1 were re-
ported: a low GH peak and low IGF-1 were observed in one subject and
a low GH peak but normal IGF-1 were observed in a second subject;
however, the remaining two subjects had normal GH peaks and IGF-1
[28]. Three of those subjects received GH treatment, and as a result,
increased their growth velocity [28]. Reminiscent of the highly pene-
trant short stature phenotype in human GHSR-A204E carriers, here we
showed that GHSR-A203E mutant mice exhibited slight albeit statis-
tically significant reductions in body length and femur length by 65e66
weeks of age (4.3% and 2.6%, respectively). Differences in these
parameters were not observed at 25 weeks of age, however, which
contrasts with the GHSR-A204E-associated growth deficiency in hu-
man carriers, which was observed in childhood [28].
Also reminiscent of the GH deficiency observed in at least some of the
human GHSR-A204E carriers, plasma IGF-1 was reduced in overnight-
fasted 65-66-week-old GHSR-A203E mice. Additionally, over the
course of a 7-d 60% caloric restriction that usually (in wild-type mice)
leads to progressive GH elevation, the GHSR-A203E mice lacked any
substantial increase in GH release. The exaggerated drop in blood
glucose observed during the caloric restriction protocol paralleled the
life-threatening severe hypoglycemia previously observed in other
genetic mouse models of reduced GHSR signaling or hepatic GH action
[24,42,48e53]. Similarly, in the GHSR-A203E mice, administered
ghrelin-induced GH secretion was negligible, while GHRH-induced GH
secretion was intact. These findings, in conjunction with increased GH
protein content observed in pituitaries of GHSR-A203E mice and intact
GHRH-induced GH release by GHSR-A203E mice, suggest a pattern of
defective GH secretion resulting from defective signaling by the GHSR-
A203E mutant.
However, the body weight phenotype of the GHSR-A203E mice did not
match that attributed to the GHSR-A204E mutation in humans. As
mentioned, several family members with the GHSR-A204E mutation
and an unrelated GHSR-A204E carrier have overweight or obesity
[28,29]. However, the body weight curves of the GHSR-A203E mice
and wild-type littermates overlapped from 4-25 weeks of age and
eventually diverged with increasing age, such that by 65e66 weeks of
age, the GHSR-A203E mice werew19.7% lighter than the wild-type
mice. Supporting the development of reduced body weight in the aged
GHSR-A203E mice, a subtle reduction in body weight gain was already
apparent in the younger GHSR-A203E mice as was a subtle reduction
in cumulative feed efficiency (in the males). Nonetheless, the younger
GHSR-A203E mice exhibited increased food intake compared to the
wild-type littermates. Notwithstanding the observation of overweight
and obesity in many human GHSR-A204E carriers, the reduction in
body weight observed in the GHSR-A203E mice fits better with the
body weight phenotype expected upon reduced GHSR signaling. Our
finding in mice suggests that the overweight and obesity phenotype of
some human GHSR-A204E carriers is unrelated to the mutation [21].MOLECULAR METABOLISM 39 (2020) 101004  2020 The Author(s). Published by Elsevier GmbH. This is an open
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seemingly discrepant observations of preserved ghrelin-dependent
GHSR activity in vitro and ex vivo vs absent or markedly reduced
ghrelin-dependent GHSR activity in vivo. Specifically, baseline Gaq-
mediated IP3 accumulation was lower in COS-7 cells transfected with
GHSR-A203E than in those transfected with GHSR-WT while ghrelin-
induced IP3 accumulation was observed in cells transfected with
either construct. Also, basal reduction in CaV2.2 current density in
CaV2.2-expressing HEK293T cells transfected with GHSR-WT was
reversed by GHSR-A203E while ghrelin-induced inhibition of CaV2.2
current density was observed in cells transfected with either construct.
These in vitro findings were similar to those observed previously for the
human GHSR-A204E construct [10] and were further supported by our
ex vivo evaluation of neurons from the wild-type mice, GHSR-A203E
mice, and GHSR-A203E-null mice. In cultured hypothalamic neurons
from the GHSR-A203E mice and GHSR-deficient mice, native calcium
currents increased compared to the wild-type mice whereas in
cultured hypothalamic neurons from the GHSR-A203E mice and wild-
type mice, ghrelin inhibited calcium currents. Also, in the brain slices,
resting membrane potentials of the arcuate NPY neurons from the
GHSR-A203E mice were hyperpolarized compared to those from the
wild-type mice, yet the same percentage of these neurons from the
GHSR-A203E and wild-type mice depolarized upon ghrelin exposure.
As such, the in vitro and ex vivo studies clearly distinguished the ef-
fects of the A203E mutation on constitutive vs ghrelin-dependent GHSR
activity and, in so doing, demonstrated a loss of constitutive GHSR
activity but retained ghrelin-induced activity. However, the in vivo
studies were not in agreement: administered ghrelin exhibited absent
orexigenic efficacy and markedly reduced GH secretagogue efficacy in
the GHSR-A203E mice. Parenthetically, it might be of interest in future
studies to determine if GHSR-A203E mice would respond more
robustly to higher doses of administered ghrelin.
Thus, the ex vivo results support the conclusions that constitutive
GHSR activity contributes to the native depolarizing conductance of
GHSR-expressing arcuate NPY neurons and that the A203E mutation
ablates constitutive GHSR activity (as those assessments were made in
cells that normally express GHSR and in preparations without ghrelin).
However, given the reduced responses to administered ghrelin in vivo
in the GHSR-A203E mice, it is uncertain whether the reduced body
weight and body length observed in the GHSR-A203E mice following
the long-term feeding study or the exaggerated decrease in blood
glucose and markedly attenuated GH elevation observed in the GHSR-
A203E mice during the 7-d 60% caloric restriction study are solely due
to the loss of constitutive GHSR activity or also to deficient ghrelin-
dependent GHSR activity. Indeed, the severe caloric restriction proto-
col was associated with an equivalently progressive increase in ghrelin
over its week-long course in both the GHSR-A203E and wild-type
littermates.
There are several potential reasons for this discrepancy. First, in vitro
studies are by nature artificial. As such, the effects on the signaling
molecules studied may not represent the effects on the actual signaling
molecules that interact with GHSR within cells that express GHSR
normally. Also, the expression levels of wild-type GHSR or the GHSR-
A203E mutant in the transfected cells may have differed from those in
cells that express GHSR normally. Additionally, the expression levels of
proteins that interact with GHSR, such as melanocortin receptor
accessory protein-2 (MRAP2) may have differed in the transfected cells
from those in native GHSR-expressing cells. MRAP2 affects GHSR
activity in many ways and is required for ghrelin-induced food intake
[54,55]. More specifically, MRAP2 potentiates ghrelin-dependent
GHSR signaling via Gaq-mediated IP accumulation, inhibitsaccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 13
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b-arrestin recruitment [54,55]. Also, co-transfection of CHO cells with
human GHSR-A204E þ MRAP2 markedly reduces ghrelin-dependent
IP accumulation over that in cells transfected with GHSR-A204E
alone [55]. Thus, differential expression levels of MRAP2 in the COS-
7 and HEK293T cells used in this study vs those occurring naturally
in cells that normally express GHSR could have contributed to the
seemingly different results observed in vitro vs in vivo for both GHSR-
WT and GHSR-A203E. As another example, previous studies revealed
that GHSR forms heterodimers with other GPCRs, including MC3R,
dopamine D1R, and dopamine D2R, among others [56e58]. For
instance, MC3R has been localized to most GHSR-expressing neurons
in the arcuate nucleus [57]. Co-transfection of COS-7 and HEK293
cells with both GHSR-WT þ MC3R diminishes GHSR constitutive
signaling and ghrelin-dependent GHSR signaling [57]. Differential
expression levels of heterodimer-forming GPCRs such as MC3R in
transfected cells vs naturally GHSR-expressing cells are undoubtedly
present.
Second, focusing on one or two signaling systems in transfected cells,
as we did in this study, may not tell the whole story. For instance, in
previous in vitro studies with the human GHSR-A204E mutant, while
certain aspects of GHSR activity were preserved upon application of
ghrelin (such as Gaq-mediated IP accumulation, as was also observed
in this study using mouse GHSR-A203E), b-arrestin recruitment (which
was reduced dramatically at baseline) could not be rescued by
application of ghrelin [14]. Additionally, the previously described het-
erodimerization of GHSR with other GPCRs also affects signaling via
those other GPCRs. For instance, co-transfection of GHSR þ MC3R
enhances a-MSH signaling via MC3R-engaged, Gas-mediated cAMP
accumulation [57]. Substitution of GHSR-A204E for wild-type GHSR
leads to reduced a-MSH-induced cAMP accumulation [57]. Thus,
while our newly reported effects of the GHSR-A203E
mutation  ghrelin on IP3 accumulation and calcium currents
in vitro suggest impaired constitutive GHSR activity and retained
ghrelin-dependent GHSR activity, had additional signaling systems
been tested, deficiencies in ghrelin-dependent GHSR activity may have
been uncovered.
Third, while ex vivo systems avoid the artificial aspects of transfection
studies, focusing on the activity of the GHSR-A203E mutation in only
hypothalamic neurons, as we did in this study, may miss effects of the
mutation in other sites of GHSR expression. For example, ghrelin’s
orexigenic actions are distributed over several GHSR-expressing brain
regions and neuronal cell types, including the caudal brainstem,
midbrain, and hippocampus in addition to several hypothalamic nuclei
[59e61]. Different subsets of these regions and others are likely
responsible to varying degrees for the ghrelin system’s other actions
[62]. Ghrelin and the endogenous GHSR antagonist/inverse agonist
LEAP2 may penetrate these different brain regions to varying degrees.
As such, it is not necessarily the case that ghrelin-dependent and
constitutive GHSR activity are engaged to the same relative degrees
from one brain region to another or that ghrelin-dependent vs
constitutive GHSR activity are relevant in all brain regions.
5. CONCLUSIONS
In vitro, ex vivo, and in vivo methods were used to investigate the
physiological significance of the GHSR-A203E mutation, a correlate of
the naturally occurring human GHSR-A204E mutation associated with
a highly penetrant occurrence of short stature, GH deficiency, and
occasional overweight or obesity. Our in vitro and ex vivo studies with
mouse GHSR-A203E confirmed previous in vitro studies with a human14 MOLECULAR METABOLISM 39 (2020) 101004  2020 The Author(s). Published by Elsevier GmbH. T
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GHSR activity but retained ghrelin-dependent GHSR activity. Remi-
niscent of the short stature and GH deficiency in human carriers, mice
expressing GHSR-A203E instead of wild-type GHSR exhibited
decreased body length and femur length when aged over one year and
defective GH secretion in response to a 7-d 60% caloric restriction
protocol. Unlike human carriers who were overweight and obese, the
aged GHSR-A203E mice attained less body weight than wild-type lit-
termates. Importantly, unlike the in vitro and ex vivo studies demon-
strating retained ghrelin-dependent GHSR activity, the GHSR-A203E
mice exhibited a loss of administered ghrelin-induced food intake and
a marked attenuation of administered ghrelin-induced GH release.
Thus, based on our ex vivo studies, we can definitively state that
constitutive GHSR activity contributes to native depolarizing conduc-
tance in arcuate NPY neurons. Also, based on our in vivo studies, we
can definitively state that the GHSR-A203E mutation causes reduced
body length, defective GH release, and diminished body weight.
However, discrepancies in ghrelin-dependent GHSR-A203E activity as
determined using the in vitro and ex vivo models vs the in vivo model
prevented us from attributing the phenotype of the GHSR-A203E mice,
and by extension, the phenotype of human carriers of the GHSR-A204E
mutation, solely to defective constitutive GHSR activity.
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